Out-licensing

We are eager to out-license our Nuntius biotechnology to mRNA players for the development of mRNA vaccines and therapies.

Last news

article

Réseau Entreprendre Auvergne has rewarded twenty projects of creation or…

posted June 20, 2016

“Réseau Entreprendre Auvergne has rewarded ...Read More

Recent Search Keywords